Mashreq prices Dim Sum bond

UAE bank raises offshore renminbi funding

Aldar buys Sharjah homes

Deal adds 1,100-plus rental units

SIB profit up 9%

Higher income from financing and investment drive growth.

Masar signs $82m land deal

Agreements signed with Abdulmohsin Al Rossais & Sons Group.

Borouge okays $656m dividend

The company said dividend reflects its resilience
  • The firm provides customized digitalization solutions.

    MBME Group operates the region’s largest online utility and government services payment platforms.

    It became the 14th company to list on the ADX Growth Market, which delivered robust performance last year.

  • The deal is worth more than $770 million, the companies said.

    The deal would mark the end the independence of Finnish mobile game makers, which burst into the scene when Rovio launched its slingshot-bird game more than a decade ago.

    The bid by Sega, famous for its own animal character, Sonic the Hedgehog, is also the latest high-profile acquisition in the gaming sector.

  • Stock markets traded mixed as last week's optimism gave way to worries that central banks may wait longer than expected...

    The dollar firmed on prospects of more US rate-tightening and oil prices slipped.

    Cooler inflation is said to have eased the pressure on the European Central Bank.

  • RAS AL KHAIMAH, UAE - A delegation from Ras Al Khaimah Economic Zone (RAKEZ) has concluded its visit to Russia...

    RAKEZ delegation met people from construction, manufacturing, information technology and fast-moving consumer goods trading.

    The audience in Russia was keen on exploring sectors such as cement, building materials, engineering services and raw materials trading.

  • Dubai, UAE – Jordan’s tourism revenue increased by 88.4 percent in the first quarter of 2023 to reach 1.18 billion...

    The revenue reached 1.18 billion Jordanian dinars ($1.66 billion) as nearly 1.5 million tourists visited the country.

    Jordan as a whole received 4.6 million visitors in 2022 -- almost four times the level from 2020 -- earning the country $5.3 billion.

  • Abu Dhabi, UAE - G42, an Abu Dhabi-based AI technology holding group, and Mubadala Investment Company on Tuesday announced the...

    M42 combines G42 Healthcare’s medical and data-centric technologies with Mubadala Health’s patient services and facilities "to provide personalised, and preventative care."

    In October 2022, G42 Healthcare and Mubadala Health announced that they had joined forces to create a new, integrated healthcare technology powerhouse.\

  • Riyadh, Saudi Arabia-- Saudi Arabia and the Netherlands have discussed the possibility of exporting clean hydrogen from the kingdom to...

    The two also discussed the kingdom's efforts in clean energy and climate change through its local and regional initiatives

    In a separate meeting, the Saudi Foreign Minister Prince Faisal bin Farhan and the Dutch minister reviewed the bilateral relations between the two nations

  • Doha, Qatar-- Inflation in Qatar rose by 4.01 percent year-on-year in March, because of a rise of prices across eight...

    Recreation and culture posted the highest increase, climbing up to 13.63 percent, according to the data released by the Planning and Statistics Authority

    During the fourth quarter of 2022, Qatari banks recorded the highest loan increase among Gulf lenders, despite a stiff interest rate environment

  • The Tesla tycoon bitterly denies that misinformation has surged since his turbulent $44 billion acquisition of the messaging platform, but...

    In a recent BBC interview, Musk pushed back at allegations that misinformation and hateful content were seeing a resurgence since his takeover.

    Twitter's ad income will drop by 28 percent this year, according to analysts at Insider Intelligence, who said "advertisers don't trust Musk."

  • The US$11bn deal will drive drug company's growth.

    At the closing of the New York Stock Exchange on Friday, Prometheus's share price stood at $114.01

    The medical company is in the middle of developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease